(NASDAQ:NUTX),
ATLANTA, March 06, 2026 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC is investigating whether Nutex Health, Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX) complied with federal securities laws. On March 5, 2026, Nutex Health announced its financial and operating results for the fourth quarter and fiscal year 2025, revealing a revenue decrease of $105.9 to $151.7 million for the three months ended December 31, 2025 due in part to a “one-time $55.0 million cumulative true-up of 18,950 arbitration claims that arbitrators determined were ineligible under the IDR process. ” The price of the Company's stock dropped following this news.
If you purchased Nutex Health stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at cholzer@holzerlaw.com or Joshua Karr, Esq. at jkarr@holzerlaw.com, call our toll-free number at (888) 508-6832, or visit our website at www.holzerlaw.com/case/nutex-health/ to discuss your legal rights.
Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, 2023, and 2025 dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content. 
CONTACT:
Corey Holzer, Esq.
(888) 508-6832 (toll-free)
cholzer@holzerlaw.com
